Back to first-pass browser

First-pass extracted concept

microRNA-155

Candidate: concept label1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

miR-155

Extracted Explainers

What the tool is doing

The abstract describes miR-155 as an endogenous regulator involved in immune function, mechano-transduction, and genetic pathways relevant to osteoarthritis. It is said to promote inflammation, cartilage matrix degradation, and chondrocyte apoptosis in OA.

Source 1DOIPubMed

What problem it solves

The review frames miR-155 as a candidate biomarker and therapeutic target for osteoarthritis, where effective diagnostic and disease-limiting strategies remain lacking.

Source 1DOIPubMed

What it does not solve

The abstract does not show that miR-155 itself is a deployable therapeutic tool or that direct miR-155-targeting interventions have been clinically validated in OA.

Source 1DOIPubMed

Alternatives

The abstract contrasts miR-155 targeting with metformin-based modulation and mentions microRNA therapeutics such as mimics and antagomiRs.

Source 1DOIPubMed

Evidence Snippets

Recent studies have recognized the involvement of microRNA-155 (miR-155) in the pathogenesis of OA and most of its risk factors.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1biomarker potentialsupports2025Source 1DOIPubMed

miR-155 has potential as a biomarker for osteoarthritis diagnosis and disease progression.

Claim 2disease mechanismsupports2025Source 1DOIPubMed

miR-155 is involved in osteoarthritis pathogenesis and risk-factor biology.

Claim 3disease mechanismsupports2025Source 1DOIPubMed

miR-155 promotes systemic and local articular inflammation, cartilage matrix degradation, and chondrocyte apoptosis in osteoarthritis-related contexts.

Claim 4pathway convergencesupports2025Source 1DOIPubMed

Metformin targets cellular pathways overlapping with miR-155 and may modulate miR-155 expression, suggesting potentially synergistic disease-modifying effects in osteoarthritis.